Spots Global Cancer Trial Database for idh1 mutation myeloid neoplasms
Every month we try and update this database with for idh1 mutation myeloid neoplasms cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
IDH1 Inhibition Using Ivosidenib as Maintenance Therapy for IDH1-mutant Myeloid Neoplasms Following Allogeneic Stem Cell Transplantation | NCT03564821 | IDH1 Mutation M... | Ivosidenib | 18 Years - | Massachusetts General Hospital |